跳至主要内容
临床试验/NCT01461291
NCT01461291已完成不适用

A Prospective, Randomized, Single-Masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery

Glaukos Corporation2 个研究点 分布在 1 个国家目标入组 505 人开始时间: 2012年1月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
505
试验地点
2
主要终点
≥ 20% Reduction in Intraocular Pressure (IOP)

研究概览

简要总结

Evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery vs. cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.

详细描述

The purpose of this study is to evaluate the safety and efficacy of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 using the G2-M-IS injector system in conjunction with cataract surgery, compared to cataract surgery only, in subjects with mild to moderate primary open-angle glaucoma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Mild to moderate open-angle glaucoma
  • Characteristics consistent with mild/moderate glaucoma
  • Use of one (1) to three (3) medications at time of screening exam

排除标准

  • Pigmentary or pseudoexfoliative glaucoma
  • Prior incisional glaucoma surgery

结局指标

主要结局

≥ 20% Reduction in Intraocular Pressure (IOP)

时间窗: Baseline and Month 24

次要结局

  • Diurnal IOP Reduction from Baseline(Baseline and Month 24)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验